Publications by authors named "D Miric"

Background: The impact of timing of invasive coronary angiography (ICA) and management strategies on in-hospital outcomes among unselected all-comers with non-ST-segment elevation myocardial infarction (NSTEMI) presents an equipoise in clinical practice.

Methods: Patients with NSTEMI from the US NIS database during 2016 to 2021 were included in the analysis. In-hospital outcomes were examined according to the timing of ICA - early (<24 h), intermediate (24-72 h), and delayed (>72 h).

View Article and Find Full Text PDF

Acutely decompensated heart failure is one of the leading causes of hospitalisation worldwide, with a significant majority of these cases attributed to congestion. Although congestion is commonly mistaken for volume overload, evidence suggests that decompensation can occur without significant water accumulation, being attributed to volume redistribution. Yet, the distinction between intravascular and extravascular congestion in heart failure often blurs, as patients frequently exhibit overlapping features of both, and as patients may transition between phenotypes over time.

View Article and Find Full Text PDF
Article Synopsis
  • - The SGLT2 inhibitor empagliflozin has been approved for treating all types of heart failure, including the less common bradycardia-induced heart failure with preserved ejection fraction (HFpEF), a condition characterized by heart function maintaining normal pumping ability despite underlying issues.
  • - A case study details a 32-year-old woman with no previous medical issues who experienced fatigue and exercise intolerance, leading to a diagnosis of junctional bradycardia and HFpEF, confirmed through various diagnostic imaging and tests.
  • - The patient's symptoms improved significantly after treatment with empagliflozin and theophylline, showcasing that bradycardia-induced HFpEF can effectively be managed with these medications even when traditional
View Article and Find Full Text PDF